BioCentury
ARTICLE | Company News

Atomwise identifying small molecules for Pfizer

September 21, 2018 4:43 PM UTC

Atomwise Inc. (San Francisco, Calif.) partnered with Pfizer Inc. (NYSE:PFE) to use its AI platform to identify small molecule candidates for up to three target proteins from Pfizer. Atomwise will receive an undisclosed technology access fee and is eligible for milestones for each target.

Atomwise’s platform is designed to use millions of affinity measurements and thousands of protein structures to predict small molecules with high affinity to target proteins. The company said it will work with Pfizer’s scientists to define the standards for hits’ potency and chemical properties...

BCIQ Company Profiles

Atomwise Inc.

Pfizer Inc.